CD4 and amyotrophic lateral sclerosis: In a post-hoc analysis on a limited number of samples, we found that, with respect to controls, at baseline ALS patients showed a trend towards higher percentages of Th1 CD4 + T cells that remained similar after 18 weeks (Fig. S2).